“The cat is out of the bag.” — Adam Waickman, PhD, of SUNY Upstate Medical University in Syracuse, New York, discussing the large dengue outbreaks in Florida and warning of further spread across the U.S.
“It’s an open question, and it’s a really interesting one.” — Christina Chambers, PhD, MPH, of the University of California San Diego, on whether early-life exposure to dupilumab (Dupixent) could lower a child’s long-term risk of atopic conditions, amid data showing exposure in pregnancy appeared safe.
“It is a reality in the MS field that this does happen.” — Marisa McGinley, DO, of the Cleveland Clinic, discussing actress Christina Applegate’s incorrect multiple sclerosis diagnosis.
“Everyone just attributed it to straightforward constipation without stopping to think, why? Is there something else going on?” — Lynn Sinitsky, MBBS, of the West Hertfordshire Teaching Hospitals NHS Trust in England, on the exceptionally rare case of a misdiagnosed infant who was later found to have a second colon.
“This is good news for women.” — JoAnn Manson, MD, MPH, DrPH, of Harvard Medical School in Boston, on a meta-analysis showing that non-hormonal menopause drugs can ease sleep disturbances.
“Medicine is very good at recording what is wrong with a patient; we need to be just as good at preserving what matters to them.” — Angelo Volandes, MD, MPH, of Dartmouth Health in Lebanon, New Hampshire, who presented research on a video decision support tool that boosted advance care planning documentation in patients nearing kidney failure.
“That gives us and other researchers super-interesting biological questions to pursue.” — Ellen Bradley, MD, of the University of California San Francisco, on a small trial that linked the psychedelic psilocybin with reduced markers of systemic inflammation and mitochondrial stress in patients with Parkinson’s disease.
